Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leff

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
BMJ (Clinical Research Ed.)|October 18, 2003
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trialLeif Bjermer, Hans Bisgaard, Jean Bousquet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluationBruce R Schackman, Jared A Leff, Michael Botsko, et al.
Thorax|March 4, 2003
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthmaD B Price, D Hernandez, P Magyar, et al.
Drug and Alcohol Dependence|August 11, 2020
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trialAli Jalali, Danielle A Ryan, Philip J Jeng, et al.
The Journal of Pediatrics|May 9, 2001
Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover studyF E Simons, J R Villa, B W Lee, et al.
Annals of the American Thoracic Society|August 29, 2014
Open-access biorepository for idiopathic pulmonary fibrosis. The way forwardEric S White, Kevin K Brown, Harold R Collard, et al.
AIDS (London, England)|March 28, 2014
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patientsBenjamin P Linas, Devra M Barter, Jared A Leff, et al.
Addiction Science & Clinical Practice|November 15, 2018
Closing the gaps in opioid use disorder research, policy and practice: conference proceedingsMatthew A Miclette, Jared A Leff, Isabella Cuan, et al.
Substance Abuse Treatment, Prevention, and Policy|April 9, 2021
Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder researchMichelle A Papp, Jared A Leff, Sean M Murphy, et al.
Drug and Alcohol Dependence|September 14, 2012
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trialBruce R Schackman, Lisa R Metsch, Grant N Colfax, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|October 18, 2003
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trialLeif Bjermer, Hans Bisgaard, Jean Bousquet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluationBruce R Schackman, Jared A Leff, Michael Botsko, et al.
Thorax|March 4, 2003
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthmaD B Price, D Hernandez, P Magyar, et al.
Drug and Alcohol Dependence|August 11, 2020
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trialAli Jalali, Danielle A Ryan, Philip J Jeng, et al.
The Journal of Pediatrics|May 9, 2001
Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover studyF E Simons, J R Villa, B W Lee, et al.
Annals of the American Thoracic Society|August 29, 2014
Open-access biorepository for idiopathic pulmonary fibrosis. The way forwardEric S White, Kevin K Brown, Harold R Collard, et al.
AIDS (London, England)|March 28, 2014
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patientsBenjamin P Linas, Devra M Barter, Jared A Leff, et al.
Addiction Science & Clinical Practice|November 15, 2018
Closing the gaps in opioid use disorder research, policy and practice: conference proceedingsMatthew A Miclette, Jared A Leff, Isabella Cuan, et al.
Substance Abuse Treatment, Prevention, and Policy|April 9, 2021
Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder researchMichelle A Papp, Jared A Leff, Sean M Murphy, et al.
Drug and Alcohol Dependence|September 14, 2012
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trialBruce R Schackman, Lisa R Metsch, Grant N Colfax, et al.
Pageof 17